Among tumors with chromosome 22 loss, we detected non-NF2 driver mutations at a higher rate in meningiomas without NF2 mutations than in meningiomas with NF2 mutations, suggesting that NF2 was not equivalently inactivated in the two groups. The gene discussed is NF2; the disease is meningioma.